Xanthus' Symadex(TM) shows Remyelination in Multiple Sclerosis Animal Model

Symadex was found to produce remyelination in the study even after 40 days of inflammatory insult by preventing the infiltration of autoreactive cells into the central nervous system. Treatment proved to be effective in both the acute and chronic presentations of disease.
Well, in the lab …on mice.